drug · small molecule
patient view →AZ-002
Phase 3updated 2mo agoby UCB SA🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 7 investigational indications.
targets
GABA-A receptor; anion channel
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that